Fimasartan/Amlodipine/Rosuvastatin

· Boryung Pharmaceutical Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fimasartan/Amlodipine/Rosuvastatin, covering 2019-06-10 to 2019-06-10. Get the full timeline:

Most recent: Clinical Trial Update: Combination of Fimasartan/Amlodipine/Rosuvastatin in Patients With Essential Hypertension and Dyslipidemia [Phase 3]

See pricing